希斯甲基转移酶KMT2D是血统可塑性和治疗反应的关键调解者,用于割抵抗性前列腺癌的治疗反应
Srushti Kittane1, Erik Ladewig2, Taibo Li3
1Johns Hopkins University Baltimore United States.
Cancer research
|December 11, 2025
概括
基隆甲基转移酶KMT2D在前列腺癌的进展中起着至关重要的作用. 将KMT2D与PI3K/AKT通路一起定位可能为割抵抗性前列腺癌 (CRPC) 亚型提供新的组合疗法.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 抗化前列腺癌 (CRPC) 通常依赖于雄激素受体 (AR) 信号或过度活跃的PI3K通路.
- 治疗耐药性可以将CRPC驱动到AR独立的干细胞样 (SCL) 表型.
- 了解表观遗传调节是开发有效CRPC治疗的关键.
研究的目的:
- 调查表观遗传机制在维持不同CRPC亚型中的作用.
- 为了确定AR-依赖和AR-独立CRPC表型的关键调节者.
- 在CRPC中探索KMT2D作为潜在的治疗点.
主要方法:
- 使用的CRPC细胞系,患者衍生器官和患者样本.
- 进行了染色质检测和单细胞转录组学.
- 研究了KMT2D在调节转录因子 (AR,FOXA1,AP-1/FOSL1) 的功能.
主要成果:
- 在依赖AR的CRPC中,KMT2D对于AR和FOXA1的招聘至关重要.
- 通过控制像FOSL1.1这样的AP-1TFs,KMT2D意外地维持了AR低的CRPC-SCL亚型.
- 联合抑制PI3K/AKT和KMT2D抑制了两种CRPC亚型的扩散.
结论:
- KMT2D是亚型特定CRPC中的关键表观遗传媒介.
- KMT2D影响关键转录因子的染色质可访问性.
- 针对KMT2D提供了一个有前途的策略,用于CRPC的组合疗法.
更多相关视频
10:33Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
Published on: October 15, 2018
8.6K
06:07Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
2.9K
相关概念视频
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Master Transcription Regulators
7.6K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.6K
Spreading of Chromatin Modifications
9.2K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
9.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Methods of Nuclear Reprogramming
2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K
Chromatin Modification in iPS Cells
2.1K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.1K
